Rheumatoid Arthritis Pathophysiology

Cel-Sci Corporation - Consensus Indicates Potential 44.7% Upside    DirectorsTalk Interviews

New technique offers chemists unprecedented control in drug research    Phys.org

Tocilizumab in patients with severe COVID-19: a retrospective cohort study    The Lancet

Synoviocyte-targeted therapy synergizes with TNF inhibition in arthritis reversal    Science Advances

Covid-19: Kawasaki-like condition in infected children needs to be studied    The Financial Express

4 Recommendations for Treating Fatigue in RA    Rheumatology Network

Tiziana Life Sciences Announces Agreement with STC Biologics for GMP Manufacturing of an anti-Interleukin-6-Receptor Monoclonal Antibody for Clinical    PharmiWeb.com

Looking Back, UK Patients Unhappy With Adalimumab Biosimilar Switch    The Center for Biosimilars

Tocilizumab in patients with severe COVID-19: a retrospective cohort study    The Lancet

Cel-Sci Corporation - Consensus Indicates Potential 44.7% Upside    DirectorsTalk Interviews

Celltrion Healthcare Receives Positive CHMP Opinion for an Additional Five Indications for Remsima® SC Including for Use in Inflammatory Bowel Disease and Ankylosing Spondylitis    The Baytown Sun

Celltrion Healthcare Receives Positive CHMP Opinion for an Additional Five Indications for Remsima® SC Including for Use in Inflammatory Bowel Disease and Ankylosing Spondylitis    The Baytown Sun

Screeners, navigators and nudgers: The future of conversational AI in healthcare    Healthcare IT News

Daily Dose: Is It Safe To Continue To Get Infusions For RA During Pandemic?    news9.com KWTV

Daily Dose: Is It Safe To Continue To Get Infusions For RA During Pandemic?    news9.com KWTV

Life Sciences Construction Amid COVID-19    Lab Manager Magazine

RINVOQ™ (upadacitinib) Monotherapy Shows Improvement in Skin Clearance and Itch in First Phase 3 Study for Atopic Dermatitis    BioSpace

Exagen and the Ohio State Innovation Foundation Announce Exclusive License Agreement and Research Collaboration for a Novel, Rule-In, Blood Test to Support the Diagnosis of Fibromyalgia    GlobeNewswire

Federal Agency Halted Funding for New Lung Treatments    The Olympian

Exagen, Ohio State Innovation Foundation Partners to Develop Fibromyalgia Test    360Dx

Federal Agency Halted Funding for New Lung Treatments    The Olympian

AbbVie's Rinvoq passes PhIII AD test; Dicerna races Alnylam; New Sarepta gene & cell collab    Endpoints News

Lilly Begins a Phase 3 Clinical Trial with Baricitinib for Hospitalized COVID-19 Patients    BioSpace

Exagen, Ohio State Innovation Foundation Partners to Develop Fibromyalgia Test    360Dx

RINVOQ™ (upadacitinib) Monotherapy Shows Improvement in Skin Clearance and Itch in First Phase 3 Study for Atopic Dermatitis    BioSpace

AbbVie's Rinvoq passes PhIII AD test; Dicerna races Alnylam; New Sarepta gene & cell collab    Endpoints News

Coronavirus: Dexamethasone proves first life-saving drug    BBC News

Coronavirus can set off a 'Cytokine Storm'. These drugs may calm it.    Times of India

What is dexamethasone, and how can it help treat coronavirus?    The Telegraph

June 15 coronavirus news    CNN

Navidea Biopharmaceuticals Announces Full Enrollment in its Ongoing Phase 2B Trial of Tc99m Tilmanocept in Rheumatoid Arthritis (RA)    GlobeNewswire

WHO halts hydroxychloroquine trials on Covid-19 patients, Europe News & Top Stories    The Straits Times

Dexamethasone could lead scientists to better COVID-19 drugs    Los Angeles Times

Navidea Biopharmaceuticals Announces Full Enrollment in its Ongoing Phase 2B Trial of Tc99m Tilmanocept in Rheumatoid Arthritis (RA)    BioSpace

AUTOIMMUNE DISEASE TREATMENT MARKET IS THRIVING WITH RISING LATEST TRENDS BY 2027 | TOP PLAYERS-ABBOTT LABORATORIES, AMGEN INC., JOHNSON & JOHNSON, ELI LILLY & CO., PFIZER    Jewish Life News

Several Coronavirus Treatments Besides Remdesivir Show Promise : Shots - Health News    NPR

NIH tests cancer drug that might help treat some of the worst symptoms of COVID-19    FOX 35 Orlando

Lilly testing third potential treatment for COVID-19    Indianapolis Business Journal

US revokes emergency use of malaria drugs versus coronavirus    KSTP

The Best Arthritis Diet—and the Worst Foods for Arthritis | Better Homes & Gardens    BH&G

Coronavirus Can Set Off a ‘Cytokine Storm.’ These Drugs May Calm It.    The New York Times

Coronavirus Can Set Off a ‘Cytokine Storm.’ These Drugs May Calm It.    The New York Times

'Major UK drug trial to test potential therapeutics for COVID-19'    Business Insider India

Judge Allows Whistleblower Suit Against Myriad Genetics to Proceed    360Dx

Rheumatoid Arthritis Drug Could Be Repurposed To Treat COVID-19 Patients    Technology Networks

EULAR advocates deployment of health care professionals -- study confirms effectiveness    EurekAlert

Coronavirus has more than one gateway into cells; Moderna vaccine clears safety hurdle in mouse study    Deccan Herald

Coronavirus has more than one gateway into cells; Moderna vaccine clears safety hurdle in mouse study    Deccan Herald

Immunovia Raised ~ 400m SEK to Further Accelerate the Market Introduction of the First Test for Early Detection of Pancreatic Cancer, the IMMray(TM) PanCan-d    WFMZ Allentown

Eli Lilly Covid-19 treatments may be ready by September    ShareCast

EULAR Report: High Disease Activity in RA Linked to Venous Thromboembolism    Rheumatology Network

Novel Antibody Drug Conjugate ABBV-3373 Shows Improvement in Disease Activity in Phase 2a Study of Patients with Rheumatoid Arthritis    PRNewswire

Sandoz Canada receives Health Canada approval to launch two oncology biosimilars: Ziextenzo® and Riximyo® | 2020-06-09 | Press Releases    Stockhouse

In Peoria, clinical trials and a new medicine are bringing hope to the sickest COVID-19 patients    Canton Daily Ledger

BioWorld MedTech's Orthopedics Extra for June 10, 2020 | 2020-06-10 | BioWorld    BioWorld Online

Down to the bone: Understanding how bone-dissolving cells are generated: Scientists explain the role of a certain protein in the generation of cells critical to bone maintenance    Science Daily

Positive Results Treating Active Psoriatic Arthritis with Upadacitinib    MD Magazine

ArthritisPower® Data Shows that Patient Engagement with Digital Tools Enhances Understanding of Arthritis – Welcomed News Amidst Worldwide Pandemic Forcing Digital Engagement    Business Wire

Nanoparticle Treatment Showing Promise Against Rheumatoid Arthritis    MD Magazine

Nanoparticle Treatment Showing Promise Against Rheumatoid Arthritis    MD Magazine

Tofacitinib Reduces Psychiatric Disorder Rates in Rheumatoid Arthritis Patients    MD Magazine

Upadacitinib Improves Rheumatoid Arthritis Symptoms Over Abatacept    MD Magazine

Tofacitinib Reduces Psychiatric Disorder Rates in Rheumatoid Arthritis Patients    MD Magazine

Philip Mease, MD: The Relationship Between Psoriatic Arthritis and IBD    MD Magazine

Stanford researcher Genovese joins Gilead to lead NASH, arthritis programs    FierceBiotech

Positive Results Treating Active Psoriatic Arthritis with Upadacitinib    MD Magazine

EULAR 2020: Lilly Shares New Data for Olumiant® in Rheumatoid Arthritis and Systemic Lupus Erythematosus    KPCnews.com

ArthritisPower® Data Shows that Patient Engagement with Digital Tools Enhances Understanding of Arthritis – Welcomed News Amidst Worldwide Pandemic Forcing Digital Engagement    Business Wire

Mark Genovese Joins Gilead to Lead Clinical Development of Company's Inflammation Programs    Business Wire

Bristol-Myers Squibb (BMY) Announces New Data Reinforce Improved and Durable Clinical Responses of Orencia in Moderate-to-Severe Early Rheumatoid Arthritis Patients with Autoantibodies Linked to More    StreetInsider.com

Hope dims for hydroxychloroquine even as medical study detailing the drug’s failure is retracted    MarketWatch

Less Than One Year Post Launch, AbbVie's Rinvoq Disrupts the Rheumatoid Arthritis Treatment Landscape, While a Rich Pipeline Waits in the Wings    PRNewswire

Hydroxychloroquine not linked to heart failure in rheumatoid arthritis    Healio

Upadacitinib Improves Rheumatoid Arthritis Symptoms Over Abatacept    MD Magazine

Rheumatoid Arthritis Diagnosis & Tests | Confirming a Diagnosis    DrugWatch.com

RA Patients With ACPA or RF Positivity Less Likely to Discontinue Abatacept    MD Magazine

EULAR 2020: Lilly Shares New Data for Olumiant® in Rheumatoid Arthritis and Systemic Lupus Erythematosus    KPCnews.com

Latent class trajectory modelling of 2‐components‐DAS28 identifies multiple rheumatoid arthritis phenotypes of response to biologic disease modifying anti‐rheumatic drugs    MD Linx

In Peoria, clinical trials and a new medicine are bringing hope to the sickest COVID-19 patients    Kewanee Star Courier

In Peoria, clinical trials and a new medicine are bringing hope to the sickest COVID-19 patients    Kewanee Star Courier

In Peoria, clinical trials and a new medicine are bringing hope to the sickest COVID-19 patients    Kewanee Star Courier

Hydroxychloroquine not linked to heart failure in rheumatoid arthritis    Healio

Rheumatoid Arthritis Diagnosis & Tests | Confirming a Diagnosis    DrugWatch.com

Stanford researcher Genovese joins Gilead to lead NASH, arthritis programs    FierceBiotech

ArthritisPower® Data Shows that Patient Engagement with Digital Tools Enhances Understanding of Arthritis – Welcomed News Amidst Worldwide Pandemic Forcing Digital Engagement    Business Wire

Mark Genovese Joins Gilead to Lead Clinical Development of Company's Inflammation Programs    Business Wire

AbbVie Submits Regulatory Applications to FDA and EMA for RINVOQ™ (upadacitinib) for the Treatment of Adults with Active Psoriatic Arthritis    PharmiWeb.com

Bristol-Myers Squibb (BMY) Announces New Data Reinforce Improved and Durable Clinical Responses of Orencia in Moderate-to-Severe Early Rheumatoid Arthritis Patients with Autoantibodies Linked to More    StreetInsider.com

Black-owned beauty brands to shop and support    Yahoo Lifestyle

Less Than One Year Post Launch, AbbVie's Rinvoq Disrupts the Rheumatoid Arthritis Treatment Landscape, While a Rich Pipeline Waits in the Wings    Bradford Era

Less Than One Year Post Launch, AbbVie's Rinvoq Disrupts the Rheumatoid Arthritis Treatment Landscape, While a Rich Pipeline Waits in the Wings    Daily American Online

EULAR 2020: Lilly Shares New Data for Olumiant® in Rheumatoid Arthritis and Systemic Lupus Erythematosus    PRNewswire

WHO Has Temporarily Suspended All COVID-19 Trials on Hydroxychloroquine    ScienceAlert

AbbVie Submits Regulatory Applications to FDA and EMA for RINVOQ™ (upadacitinib) for the Treatment of Adults with Active Psoriatic Arthritis    Yahoo Finance